HAPILA commits to rescheduled Chemspec Europe Exhibition

HAPILA GmbH News Releases

Find the latest News from HAPILA GmbH

Home / News Releases

HAPILA commits to rescheduled Chemspec Europe Exhibition

HAPILA commits to rescheduled Chemspec Europe Exhibition

Tuesday 12th May 2020

By HAPILA GmbH Learn More >

HAPILA extends commitment to ‘green’ energy

HAPILA extends commitment to ‘green’ energy

Monday 23rd March 2020

By HAPILA GmbH Learn More >

HAPILA’s BTZ-043 anti TB agent commences human trials

Thursday 9th January 2020

By HAPILA GmbH Learn More >

HAPILA showcases advanced API development expertise at CPhI Worldwide Frankfurt

HAPILA showcases advanced API development expertise at CPhI Worldwide Frankfurt

Wednesday 23rd October 2019

By HAPILA GmbH Learn More >

HAPILA gains ISO certification and FDA approval

Friday 4th October 2019

By HAPILA GmbH Learn More >

HAPILA anti-TB agent BTZ043 wins Germany’s IQ Innovation Award

HAPILA anti-TB agent BTZ043 wins Germany’s IQ Innovation Award

Friday 9th August 2019

By HAPILA GmbH Learn More >

Anti-TB substance BTZ-043 passes Clinical Trial Phase Ia milestone

Wednesday 17th July 2019

By HAPILA GmbH Learn More >

HAPILA showing advanced drug CDMO services at Chemspec Europe

Wednesday 12th June 2019

By HAPILA GmbH Learn More >

HAPILA gains cGMP status for leading edge anti-tuberculosis API manufacture

Tuesday 7th May 2019

By HAPILA GmbH Learn More >